Northwestern Mutual Wealth Management CO Intercept Pharmaceuticals, Inc. Transaction History

Northwestern Mutual Wealth Management CO

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $2,997 - $5,613	300 Added 1500.0%	320 $5,000
Q2 2023 Aug 14, 2023	SELL	$9.17 - $19.29 $495 - $1,041	-54 Reduced 72.97%	20 $0
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $676 - $1,172	54 Added 270.0%	74 $0
Q3 2022 Nov 14, 2022	SELL	$12.21 - $19.7 $818 - $1,319	-67 Reduced 77.01%	20 $0
Q2 2022 Aug 04, 2022	SELL	$11.23 - $19.59 $370 - $646	-33 Reduced 27.5%	87 $1,000
Q1 2022 May 09, 2022	BUY	$13.37 - $17.79 $1,337 - $1,779	100 Added 500.0%	120 $2,000
Q2 2021 Aug 13, 2021	SELL	$15.46 - $24.5 $1,777 - $2,817	-115 Reduced 85.19%	20 $0
Q1 2021 May 14, 2021	BUY	$19.33 - $37.75 $2,222 - $4,341	115 Added 575.0%	135 $3,000
Q4 2020 Feb 12, 2021	SELL	$24.48 - $42.47 $2,913 - $5,053	-119 Reduced 85.61%	20 $0
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $5,557 - $10,952	119 Added 595.0%	139 $7,000
Q3 2019 Nov 12, 2019	SELL	$58.69 - $80.46 $9,742 - $13,356	-166 Reduced 89.25%	20 $1,000
Q2 2019 Aug 12, 2019	BUY	$77.77 - $120.68 $11,276 - $17,498	145 Added 353.66%	186 $15,000
Q1 2019 May 10, 2019	SELL	$91.83 - $120.68 $12,948 - $17,015	-141 Reduced 77.47%	41 $4,000
Q4 2018 Feb 12, 2019	BUY	$85.79 - $126.46 $12,782 - $18,842	149 Added 451.52%	182 $18,000
Q3 2018 Nov 01, 2018	SELL	$88.49 - $127.55 $7,698 - $11,096	-87 Reduced 72.5%	33 $5,000
Q2 2018 Aug 10, 2018	BUY	$60.0 - $85.67 $1,980 - $2,827	33 Added 37.93%	120 $10,000
Q3 2017 Nov 07, 2017	BUY	$57.01 - $118.75 $4,959 - $10,331	87	87 $5,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.